$8.66
0.283.34%
At close: -
$8.92
0.263.00%
After Hours: Apr 25, 7:00 AM EDT
Comments
Loading...
OptimizeRx Stock Guidance | NASDAQ:OPRX | Benzinga
OptimizeRx issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/12/2025 | OPRX | OptimizeRx | FY | 2025 | — | — | — | $100.00M | $100.00M | $99.65M | Get Alert |
| 12/23/2024 | OPRX | OptimizeRx | FY | 2024 | — | — | — | $92.00M | $92.00M | $89.50M | Get Alert |
| 11/13/2024 | OPRX | OptimizeRx | FY | 2024 | — | — | — | $88.00M | $92.00M | $100.69M | Get Alert |
| 08/08/2024 | OPRX | OptimizeRx | FY | 2024 | — | — | — | $100.00M | — | $101.46M | Get Alert |
| 05/14/2024 | OPRX | OptimizeRx | FY | 2024 | — | — | — | $100.00M | — | $101.31M | Get Alert |
| 04/26/2024 | OPRX | OptimizeRx | Q1 | 2024 | — | — | — | $18.50M | $19.20M | $17.03M | Get Alert |
| 04/16/2024 | OPRX | OptimizeRx | FY | 2024 | — | — | — | $100.00M | — | $104.73M | Get Alert |
| 03/11/2024 | OPRX | OptimizeRx | FY | 2023 | — | — | — | $70.00M | — | $69.62M | Get Alert |
| 03/11/2024 | OPRX | OptimizeRx | FY | 2024 | — | — | — | $100.00M | — | $110.41M | Get Alert |
| 01/09/2024 | OPRX | OptimizeRx | FY | 2023 | — | — | — | $70.00M | — | $68.78M | Get Alert |
| 01/09/2024 | OPRX | OptimizeRx | FY | 2024 | — | — | — | $110.00M | — | $110.29M | Get Alert |
| 11/06/2023 | OPRX | OptimizeRx | FY | 2024 | — | — | — | $110.00M | — | $75.92M | Get Alert |
| 11/06/2023 | OPRX | OptimizeRx | FY | 2023 | — | — | — | $63.00M | $65.00M | $60.51M | Get Alert |
| 10/12/2023 | OPRX | OptimizeRx | Q3 | 2023 | — | — | — | $15.20M | $15.50M | $14.26M | Get Alert |
| 05/10/2023 | OPRX | OptimizeRx | FY | 2023 | — | — | — | $68.69M | — | $68.64M | Get Alert |
| 03/08/2023 | OPRX | OptimizeRx | FY | 2023 | — | — | — | $68.69M | — | $77.80M | Get Alert |
| 03/08/2023 | OPRX | OptimizeRx | Q1 | 2023 | — | — | — | $11.50M | $13.00M | $16.15M | Get Alert |
| 11/08/2022 | OPRX | OptimizeRx | FY | 2022 | — | — | — | $62.00M | $68.00M | $64.05M | Get Alert |
| 08/09/2022 | OPRX | OptimizeRx | FY | 2022 | — | — | — | $62.00M | $68.00M | $81.44M | Get Alert |
| 05/04/2022 | OPRX | OptimizeRx | FY | 2022 | — | — | — | $80.00M | $85.00M | $81.83M | Get Alert |
| 02/24/2022 | OPRX | OptimizeRx | FY | 2022 | — | — | — | $80.00M | $85.00M | $81.61M | Get Alert |
| 02/15/2022 | OPRX | OptimizeRx | Q4 | 2021 | — | — | — | $20.30M | $20.30M | $20.24M | Get Alert |
| 02/15/2022 | OPRX | OptimizeRx | FY | 2022 | — | — | — | $80.00M | $85.00M | $81.59M | Get Alert |
| 01/25/2021 | OPRX | OptimizeRx | Q4 | 2020 | — | — | — | $16.00M | $16.00M | $11.10M | Get Alert |
| 01/25/2021 | OPRX | OptimizeRx | FY | 2020 | — | — | — | $43.00M | $43.00M | $37.99M | Get Alert |
| 10/13/2020 | OPRX | OptimizeRx | Q3 | 2020 | — | — | — | $10.00M | — | $9.10M | Get Alert |
FAQ
What is the most recent guidance for OptimizeRx (OPRX)?
There have been no specific sales or earnings guidance reported for OptimizeRx in recent months.
Browse guidance and forecast on all stocks.
